Dow Up 0.51% Nasdaq Up 0.24%

BIND Therapeutics, Inc. (BIND)

-NasdaqGS
7.55 Down 0.06(0.79%) Nov 21, 4:00PM EST
|After Hours : 7.50 Down 0.05 (0.66%) Nov 21, 4:39PM EST
Prev Close:7.61
Open:7.90
Bid:N/A
Ask:7.99 x 100
1y Target Est:23.33
Beta:N/A
Next Earnings Date:N/A
Day's Range:7.50 - 7.90
52wk Range:7.50 - 15.77
Volume:359,016
Avg Vol (3m):118,126
Market Cap:124.93M
P/E (ttm):N/A
EPS (ttm):-1.95
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for BIND

Comparison

Symbol% ChgMkt Cap
BINDDown 0.79%124.93M
BMYUp 0.32%97.54B
PGNXUp 5.45%470.89M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.90
Quarterly EPS Est (Dec-14) :-0.46
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company, develops various targeted and programmable therapeutics. It is developing Accurins that are designed with specified physical and chemical characteristics to target specific c... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback